Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most aggressive types of lung cancer and carries a five year survival rate of just five percent. Although many patients initially respond well to chemotherapy, these benefits […]Health,Cancer,Immunology,Lung Cancer,Oncology,University of Cologne#Inflammation #Supercharges #Deadliest #Cancers1767821338
Recent Post
Gallery
Featured Videos
